Prevalence of Hepatitis B Infection in the Galilee Region, Israel
NCT ID: NCT01645007
Last Updated: 2014-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Evaluate HBV (Hepatitis B Virus) infection prevalence among Druze in the Galilee.
2. Educate the population in order to reduce transmission
3. Increase awareness among primary care providers
Secondary Aims:
1. Identify chronic HBV infected patients who need to be followed and treated,
2. Identify HBV infected women in a childbearing age
3. Identify non immunized individuals and recommend vaccination
4. Identify previously vaccinated individuals who are not immunized
5. Identify previously vaccinated individuals who became infected
Study Design:
Study population is targeted to native Israeli Druze. We aim for evaluating up to 20,000 people from Druze communities in the Galilee area
This work will be divided into three sections:
1. Increasing awareness: lectures and local events will be taken place in the communities. Written information will be given and primary care-providers mainly family doctors, nurses and obstetric surgeons will be involved.
2. All participants, upon signing a consent will:
* Fill up a questioner
* Checked for weight, height and waist circumflex
* Have a blood sample taken
3. Results and recommendations will be forwarded to all participants
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
NCT06906016
Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination
NCT05523921
Impact of Hepatitis B Vaccination on HBs Antigenemia
NCT03193775
"Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
NCT01732081
Increasing Hepatitis B Screening Among Korean Church Attendees
NCT00760721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Individuals who cannot or will not sign consent
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western Galilee Hospital-Nahariya
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0025-12-NHR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.